121 related articles for article (PubMed ID: 31590158)
1. Targeting PD-L1 After Adjuvant Radiation in Subtotally Resected Primary Pineal Melanoma: A Case Report and Literature Review.
Famoso J; Lemole G; Sundararajan S; Stea B
J Natl Compr Canc Netw; 2019 Oct; 17(10):1148-1153. PubMed ID: 31590158
[TBL] [Abstract][Full Text] [Related]
2. Primary Malignant Melanoma in the Pineal Region: Case Report and Literature Review.
Wendel C; Kaech DL; Woodtli M
J Neurol Surg A Cent Eur Neurosurg; 2018 Jul; 79(4):344-352. PubMed ID: 29649851
[TBL] [Abstract][Full Text] [Related]
3. Surgical resection and adjuvant radiotherapy for a large pineal hemangiopericytoma.
Jian BJ; Han SJ; Yang I; Waldron JS; Tihan T; Parsa AT
J Clin Neurosci; 2010 Sep; 17(9):1209-11. PubMed ID: 20598546
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma.
Eggermont AMM; Blank CU; Mandala M; Long GV; Atkinson V; Dalle S; Haydon A; Lichinitser M; Khattak A; Carlino MS; Sandhu S; Larkin J; Puig S; Ascierto PA; Rutkowski P; Schadendorf D; Koornstra R; Hernandez-Aya L; Maio M; van den Eertwegh AJM; Grob JJ; Gutzmer R; Jamal R; Lorigan P; Ibrahim N; Marreaud S; van Akkooi ACJ; Suciu S; Robert C
N Engl J Med; 2018 May; 378(19):1789-1801. PubMed ID: 29658430
[TBL] [Abstract][Full Text] [Related]
5. Primary pineal melanoma: case report.
Rubino GJ; King WA; Quinn B; Marroquin CE; Verity MA
Neurosurgery; 1993 Sep; 33(3):511-5; discussion 515. PubMed ID: 8413885
[TBL] [Abstract][Full Text] [Related]
6. Programmed Death-Ligand 1 Expression and Response to the Anti-Programmed Death 1 Antibody Pembrolizumab in Melanoma.
Daud AI; Wolchok JD; Robert C; Hwu WJ; Weber JS; Ribas A; Hodi FS; Joshua AM; Kefford R; Hersey P; Joseph R; Gangadhar TC; Dronca R; Patnaik A; Zarour H; Roach C; Toland G; Lunceford JK; Li XN; Emancipator K; Dolled-Filhart M; Kang SP; Ebbinghaus S; Hamid O
J Clin Oncol; 2016 Dec; 34(34):4102-4109. PubMed ID: 27863197
[TBL] [Abstract][Full Text] [Related]
7. Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial.
Carlino MS; Long GV; Schadendorf D; Robert C; Ribas A; Richtig E; Nyakas M; Caglevic C; Tarhini A; Blank C; Hoeller C; Bar-Sela G; Barrow C; Wolter P; Zhou H; Emancipator K; Jensen EH; Ebbinghaus S; Ibrahim N; Daud A
Eur J Cancer; 2018 Sep; 101():236-243. PubMed ID: 30096704
[TBL] [Abstract][Full Text] [Related]
8. Combined microscope and endoscopy total resection of primary pineal malignant melanoma: case report and literature review.
Zhang J; Xiong Z; Chen J
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2589-2594. PubMed ID: 32700108
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression and prognostic value of PD-L1 in Extrapulmonary small cell carcinoma: a single institution experience.
Salhab M; Migdady Y; Donahue M; Xiong Y; Dresser K; Walsh W; Chen BJ; Liebmann J
J Immunother Cancer; 2018 May; 6(1):42. PubMed ID: 29843803
[TBL] [Abstract][Full Text] [Related]
10. Primary pineal malignant melanoma with B-Raf V600E mutation: a case report and brief review of the literature.
Jetschke K; Viehweger H; Freesmeyer M; Warnke JP; Mawrin C
Acta Neurochir (Wien); 2015 Jul; 157(7):1267-70. PubMed ID: 25976339
[TBL] [Abstract][Full Text] [Related]
11. Primary pineal malignant melanoma.
Bookland M; Anderson WS; Biser-Rohrbaugh A; Jallo GI
Pediatr Neurosurg; 2007; 43(4):303-8. PubMed ID: 17627147
[TBL] [Abstract][Full Text] [Related]
12. Pembrolizumab in Recurrent Squamous Cell Carcinoma of the Vulva: Case Report and Review of the Literature.
Shields LBE; Gordinier ME
Gynecol Obstet Invest; 2019; 84(1):94-98. PubMed ID: 30016784
[TBL] [Abstract][Full Text] [Related]
13. The Role of Adjuvant Radiotherapy in the Treatment of Papillary Tumors of the Pineal Region: Some General Considerations and a Case Report.
Lancia A; Ingrosso G; Santoni R
Klin Onkol; 2017; 30(6):456-459. PubMed ID: 29271218
[TBL] [Abstract][Full Text] [Related]
14. Long-term radiosurgical control of subtotally resected adult pineocytomas.
Wilson DA; Awad AW; Brachman D; Coons SW; McBride H; Youssef E; Nakaji P; Shetter AG; Smith KA; Spetzler RF; Sanai N
J Neurosurg; 2012 Aug; 117(2):212-7. PubMed ID: 22702479
[TBL] [Abstract][Full Text] [Related]
15. The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.
Mahoney KM; Freeman GJ; McDermott DF
Clin Ther; 2015 Apr; 37(4):764-82. PubMed ID: 25823918
[TBL] [Abstract][Full Text] [Related]
16. Glioblastoma of pineal region: report of four cases and literature review.
Orrego E; Casavilca S; Garcia-Corrochano P; Rojas-Meza S; Castillo M; Castaneda CA
CNS Oncol; 2017 Oct; 6(4):251-259. PubMed ID: 28990813
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies.
Algazi AP; Tsai KK; Shoushtari AN; Munhoz RR; Eroglu Z; Piulats JM; Ott PA; Johnson DB; Hwang J; Daud AI; Sosman JA; Carvajal RD; Chmielowski B; Postow MA; Weber JS; Sullivan RJ
Cancer; 2016 Nov; 122(21):3344-3353. PubMed ID: 27533448
[TBL] [Abstract][Full Text] [Related]
18. Extent of Resection and Long-Term Survival of Pineal Region Tumors in Helsinki Neurosurgery.
Choque-Velasquez J; Resendiz-Nieves J; Jahromi BR; Colasanti R; Raj R; Vehviläinen J; Tynninen O; Collan J; Niemelä M; Hernesniemi J
World Neurosurg; 2019 Nov; 131():e379-e391. PubMed ID: 31369883
[TBL] [Abstract][Full Text] [Related]
19. Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study.
Adams S; Loi S; Toppmeyer D; Cescon DW; De Laurentiis M; Nanda R; Winer EP; Mukai H; Tamura K; Armstrong A; Liu MC; Iwata H; Ryvo L; Wimberger P; Rugo HS; Tan AR; Jia L; Ding Y; Karantza V; Schmid P
Ann Oncol; 2019 Mar; 30(3):405-411. PubMed ID: 30475947
[TBL] [Abstract][Full Text] [Related]
20. Identification and clinical relevance of PD-L1 expression in primary mucosal malignant melanoma of the head and neck.
Thierauf J; Veit JA; Affolter A; Bergmann C; Grünow J; Laban S; Lennerz JK; Grünmüller L; Mauch C; Plinkert PK; Hess J; Hoffmann TK
Melanoma Res; 2015 Dec; 25(6):503-9. PubMed ID: 26352784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
